| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Highlights Healthcare is a company that provides diagnosis, early intervention, and ABA therapy services to bring meaningful and positive change to learners with Autism Spectrum Disorder.
InterPro Transcription Solutions. is a Sun City, AZ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
VisionShare Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Androscoggin Valley Hospital, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Berlin, NH. To find more information about Androscoggin Valley Hospital, Inc., please visit www.avhnh.org